These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11905263)

  • 21. Federal agencies issue new antitrust guidelines.
    Bentley LD
    Radiol Manage; 1995; 17(3):18, 21-3. PubMed ID: 10144825
    [No Abstract]   [Full Text] [Related]  

  • 22. Antitrust issues in the settlement of pharmaceutical patent disputes, Part II.
    Leary TB
    J Health Law; 2001; 34(4):657-71. PubMed ID: 11833411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reanalyzing reverse payment settlements: a solution to the patentee's dilemma.
    Wang Z
    Cornell Law Rev; 2014 Jul; 99(5):1227-58. PubMed ID: 25112001
    [No Abstract]   [Full Text] [Related]  

  • 24. Antitrust exemption: are health providers crying wolf?
    Barnett AA
    J Am Health Policy; 1993; 3(3):38-41. PubMed ID: 10125734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new antitrust "safe-harbors".
    Craft JA
    Integr Healthc Rep; 1993 Nov; ():11-3. PubMed ID: 10131005
    [No Abstract]   [Full Text] [Related]  

  • 26. COPAing with antitrust rules. Just three systems have used certificates of public advantage seeking antitrust immunity. Experts now say they're regulatory dinosaurs.
    Taylor M
    Mod Healthc; 2005 Feb; 35(8):30-2, 34. PubMed ID: 15765844
    [No Abstract]   [Full Text] [Related]  

  • 27. Physician organizations: two years under the FTC/DOJ guidelines.
    Enders RJ
    Health Care Law Newsl; 1995 Oct; 10(10):9-11. PubMed ID: 10151244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revised antitrust safety zones allow provider networks more flexibility.
    Roeder KH; Sledge SK
    Ga Hosp Today; 1996 Oct; 40(10):3, 5. PubMed ID: 10162572
    [No Abstract]   [Full Text] [Related]  

  • 29. Championing consumers. Leibowitz talks of challenging patent agreements, role of antitrust enforcement. Interview by Joe Carlson.
    Leibowitz J
    Mod Healthc; 2013 Feb; 43(6):18-9. PubMed ID: 23487902
    [No Abstract]   [Full Text] [Related]  

  • 30. Health care antitrust guidelines clarify enforcement policy.
    Enders RJ
    Health Care Law Newsl; 1993 Dec; 8(12):3-8. PubMed ID: 10130818
    [No Abstract]   [Full Text] [Related]  

  • 31. Justice Dept., FTC offer more antitrust guidance.
    Burda D
    Mod Healthc; 1994 Oct; 24(40):34. PubMed ID: 10137211
    [No Abstract]   [Full Text] [Related]  

  • 32. Department of Justice and Federal Trade Commission issue further guidance relating to physician network joint ventures.
    Becker S
    Benders Health Care Law Mon; 1996 Oct; ():3-4. PubMed ID: 10162603
    [No Abstract]   [Full Text] [Related]  

  • 33. Avoiding antitrust snags requires forethought and thorough market analysis.
    Engstrom P
    Med Netw Strategy Rep; 1995 May; 4(5):1-4. PubMed ID: 10153138
    [No Abstract]   [Full Text] [Related]  

  • 34. On access and accountability--two Supreme Court rulings on generic drugs.
    Boumil MM; Curfman GD
    N Engl J Med; 2013 Aug; 369(8):696-7. PubMed ID: 23923990
    [No Abstract]   [Full Text] [Related]  

  • 35. Calif. HME dealer under FTC antitrust investigation.
    Burda D
    Mod Healthc; 1991 Jul; 21(27):2-3. PubMed ID: 10111446
    [No Abstract]   [Full Text] [Related]  

  • 36. Second panel seeks records from FTC.
    Burda D
    Mod Healthc; 1992 Feb; 22(7):18. PubMed ID: 10116231
    [No Abstract]   [Full Text] [Related]  

  • 37. Antitrust law applicable to managed care contracting.
    Weber RD
    Mich Med; 1995 Apr; 94(4):16-7. PubMed ID: 7791633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitrust guide to merge missions of FTC, Justice.
    Burda D
    Mod Healthc; 1991 Nov; 21(47):34. PubMed ID: 10115002
    [No Abstract]   [Full Text] [Related]  

  • 39. FTC weighs easing antitrust rules for provider networks.
    Gardner J
    Mod Healthc; 1995 Dec; 25(50):24. PubMed ID: 10152958
    [No Abstract]   [Full Text] [Related]  

  • 40. Unsettling drug patent settlements: a framework for presumptive illegality.
    Carrier MA
    Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.